ALIOS-PES provides an integrated hardware, software, and biomaterial portfolio for suspended 3D bioprinting, enabling any lab to produce reproducible 3D tissue models without a dedicated specialist. Their BP-X3 bioprinter and validated reagent kits support multi-well throughput and long-term culture studies, with applications including full-thickness skin models and label-free ECM characterization.
- Biotechnology
- Hardware
- Healthcare Technology
- New Materials
Funding
Founders
Product
Problem
Traditional 3D bioprinting methods require specialized expertise, lengthy optimization phases, and often fail to produce reproducible results due to limitations in biomaterial compatibility and shape retention. This restricts access to advanced 3D in-vitro tissue models, particularly for labs without dedicated bioprinting specialists, and slows down research progress in bioscience and biomaterial fields.
Solution
ALIOS-PES delivers a comprehensive portfolio of hardware, software, and biomaterials designed to make suspended 3D bioprinting routine and reproducible. The core technology uses a quasi-liquid support environment that holds cell-laden biomaterials in place during gelation, decoupling shape retention from cure time and enabling the printing of complex, multi-layer structures with precise control over cell density and composition. The BP-X3 bioprinter offers µL-scale dispensing accuracy and software-enabled multi-well throughput, while fully characterized reagent kits eliminate the need for optimization. This integrated approach allows researchers to generate validated 3D tissue models, such as full-thickness skin constructs, and conduct long-term studies (21+ days) with minimal technical overhead.
Target Audience
Primary customers are bioscience and biomaterial research laboratories, including academic institutions and biotech companies, seeking to produce reproducible 3D in-vitro tissue models without dedicated bioprinting specialists.
Features
- BP-X3 bioprinter with µL-scale dispensing accuracy compatible with any bioink and software-enabled multi-well throughput
- Fully characterized support baths and bioscaffold formulations that skip the optimization phase for reproducible results
- Validated applications including technical replicates, multi-layer integration, label-free ECM characterization, and full-transcriptome RNAseq
- Support for long-timeline studies of 21 days and over with distinct layer seeding densities (0.5–1.5×10⁶ cells/ml)
- Ready-to-use SOPs, validated print files, and experimental design support based on five years of hands-on expertise